Healthcare - Biotechnology - NASDAQ - US
$ 9.63
-13.6 %
$ 477 M
Market Cap
-1.92
P/E
CASH FLOW STATEMENT
-218 M
OPERATING CASH FLOW
191 M
INVESTING CASH FLOW
-35 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
REGENXBIO Inc.
| Net Income | -263 M |
| Depreciation & Amortization | 17.3 M |
| Capital Expenditures | -9.96 M |
| Stock-Based Compensation | 40.3 M |
| Change in Working Capital | -10.9 M |
| Others | -13.6 M |
| Free Cash Flow | -228 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (263.5) | (280.3) | 127.8 | (111.2) | (94.7) | 99.9 | (73.2) | (63.0) | (22.8) | (4.0) | (5.4) |
| Depreciation & Amortization | 17.3 | 12.9 | 9.6 | 8.4 | 7.2 | 4.0 | 2.7 | 0.5 | 80 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | (1.9) | 3.8 | (39.0) | 0.8 | 1.3 | 2.0 | 0.3 | 0 | 0 |
| Stock Based Compensation | 40.3 | 40.8 | 38.8 | 31.9 | 26.9 | 16.6 | 10.6 | 7.0 | 2.9 | 0.3 | 0 |
| Other Operating Activities | (1.6) | 5.2 | 4.4 | (1.2) | (2.7) | (8.9) | (0.3) | (0.4) | 13 K | 0.2 | (0.3) |
| Change in Working Capital | (10.9) | 14.0 | 40.2 | 14.2 | (5.3) | (7.8) | 0.9 | 5.2 | (3.0) | 1.1 | 2.7 |
| Cash From Operations | (218.4) | (207.5) | 218.9 | (54.1) | (107.7) | 104.6 | (58.0) | (48.6) | (22.5) | (2.4) | (3.0) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (10.0) | (30.7) | (84.2) | (26.9) | (11.7) | (13.3) | (7.2) | (8.1) | (0.5) | 0 | 0 |
| Other Items | 200.9 | 18.8 | (322.5) | 149.6 | 105.3 | (266.1) | 2.4 | 27.3 | (163.3) | 0 | 0 |
| Cash From Investing Activities | 190.9 | (11.9) | (406.6) | 122.8 | 93.6 | (279.4) | (4.8) | 19.2 | (163.8) | 0 | 0 |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.4 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (41.7) | (30.6) | (23.0) | 198.4 | 7.1 | 13.9 | 2.0 | 0.1 | 94.1 | 1 K | 2.0 |
| Cash From Financing Activities | (35.0) | (28.8) | 195.2 | 200.2 | 8.4 | 204.4 | 84.6 | 0.1 | 239.3 | 2.4 | 2.0 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (62.4) | (248.3) | 7.5 | 268.9 | (5.8) | 29.7 | 21.8 | (29.3) | 53.0 | 2 K | (1.0) |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (228.4) | (238.2) | 134.7 | (80.9) | (119.4) | 91.4 | (65.2) | (56.7) | (23.0) | (2.4) | (3.0) |